scorecardresearch
Add as a preferred source on Google
Tuesday, December 9, 2025
TopicZydus Cadila

Topic: Zydus Cadila

Zydus Cadila’s Covid vaccine to be administered ‘only to adults as of now’

India's drug regulator cleared ZyCov-D for those aged 12 and above but Union Health Minister said his government does not want to make haste about administering Covid vaccines to children.

Zydus Cadila agrees to reduce Covid vaccine price but final deal yet to be reached: Sources

New Delhi: Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the...

2 months after vaccine approval, Covid shots for kids stuck on list of comorbidities, procedure

Zycov-D is the lone vaccine cleared for use in children in India. However, expert panel still thrashing out some issues to streamline the rollout for parents.

Modi govt drives hard bargain, ZyCov-D vaccine could cost Rs 275/dose or even less

The world’s first DNA vaccine for Covid manufactured by Gujarat-based Zydus Cadila is delivered using a special applicator costing Rs 30,000.

Vaccine makers upset over ‘differential pricing’ for ZyCov-D, and lack of clarity on exports

ZyCov-D has reportedly been priced by the company at Rs 1,900 for three doses while the others cost between Rs 205-215 per dose.

6 shots per patient, Rs 30,000 applicator gun complicate govt talks for ZyCov-D vaccine

World's first DNA vaccine, ZyCov-D is a 3-dose vaccine (administered in 2 injections each time) which requires a special needle-free applicator.

ZyCov-D price talks still on, but India begins training for use of needle-free applicator

First instalment of ZyCov-D, a three-dose Covid vaccine manufactured by Zydus Cadila, is expected next month. Vaccine doesn't require a needle injection to be administered.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Three-dose ZyCoV-D vaccine could be just two doses, says pharma firm Zydus Cadila

Zydus Cadilla says its test data shows that the vaccine appears to be just as effective in 2 doses as 3, and will be administered 28 days apart.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

On Camera

Farrhana Bhatt on Bigg Boss 19 reopened Kashmir’s representation wound

Farrhana Bhatt’s presence on Bigg Boss 19 can’t redefine Kashmir. But it can remind the Valley that Kashmiris deserve to be seen in their full human range—not squeezed into specific categories.

Niti Aayog CEO has a message for power stakeholders. Buckle up for surge to feed EVs, data centres

Clean energy is “no longer the sideshow, it is the show”, BVR Subrahmanyam told the Odisha summit, warning India to lead the global shift or risk others’ tech dominance.

India looks to Oman for spare parts to keep its fleet of Jaguars flying

India is now the only country still operating the Jaguar, long retired by its original users, France in 2005 and the UK in 2007, and secondary operators like Oman, Nigeria and Ecuador.

Asim Munir & Pakistan’s Failed Marshal Doctrine

None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.